Evaluation of the efficacy of platelet-rich plasma on healing of clean diabetic foot ulcers: A randomized clinical trial in Tehran, Iran
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, ISSN: 1871-4021, Vol: 15, Issue: 2, Page: 621-626
2021
- 29Citations
- 126Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations29
- Citation Indexes29
- 29
- Captures126
- Readers126
- 126
- Mentions1
- News Mentions1
- News1
Most Recent News
The Potential of Autologous Platelet-Rich Plasma Gel for Diabetic Foot Ulcer Care Among Older Adults: A Systematic Review and Meta-Analysis
Introduction The prevalence of Diabetes Mellitus increases significantly with age.1,2 Most diagnosed cases lie between the fourth and seventh decades of life.3 Recent statistics indicate
Article Description
Diabetic foot ulcers (DFUs) are among challenging hurdles both for the patient and the physician. There is a recent trend toward finding novel and clinically efficient modalities to treat this potentially hazardous complication of diabetes mellitus in a timely manner. Herein, we aim to appraise the efficacy of platelet-rich plasma (PRP) in healing of clean DFUs. 90 patients with clean DFUs consisting of 56 (62.2%) males and 34 (37.8%) females with mean age (±standard deviation) of 56.52 (±7.14) years were enrolled in this study between June 2017 and December 2018. They were randomly allocated into control group (47 patients who received conventional dressing along with silver sulfadiazine ointment twice daily), and case group (43 patients who received PRP gel twice weekly for 3 weeks). All the patients were followed up for 6 months. Our study showed that PRP significantly increased the healing rate of DFUs regardless of the age ( p -value: 0.0), gender ( p -value: 0.0), or smoking ( p -value: 0.0) and blood pressure ( p -value: 0.0) status of patients, but it did not have a significant impact on the need for amputation ( p -value: 0.11), level of amputation ( p -value: 0.16), or the need for further treatments such as graft or angioplasty ( p -value: 0.52). Regardless of the age, gender, or smoking and blood pressure status of patients, PRP can be efficiently used in diabetic patients to accelerate the healing rate of foot ulcers.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1871402121000734; http://dx.doi.org/10.1016/j.dsx.2021.03.005; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85102576214&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/33740736; https://linkinghub.elsevier.com/retrieve/pii/S1871402121000734; https://dx.doi.org/10.1016/j.dsx.2021.03.005
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know